Anne-Marie Martin
Director/Board Member at CULLINAN THERAPEUTICS, INC.
Net worth: - $ as of 31/05/2024
Profile
Anne-Marie Martin is an Independent Director at Cullinan Therapeutics, Inc. since 2022 and a Senior VP & Global Head-Experimental Medicine Unit at GSK Plc since 2020.
She previously worked as a Director at Cullinan Oncology LLC.
From 2016 to 2020, she was a Senior VP & Global Head-Precision Medicine at Novartis Pharma AG.
Prior to that, she served as Vice President & Head-Biomarker Research at Adaptimmune Therapeutics Plc from 2015 to 2016.
Dr. Martin holds a doctorate degree from MCP Hahnemann University and an undergraduate degree from Sheffield Hallam University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 29/04/2024 | 0 ( -.--% ) | - $ | 31/05/2024 |
Anne-Marie Martin active positions
| Companies | Position | Start |
|---|---|---|
| CULLINAN THERAPEUTICS, INC. | Director/Board Member | 01/03/2022 |
| GSK PLC | Corporate Officer/Principal | 01/08/2020 |
Former positions of Anne-Marie Martin
| Companies | Position | End |
|---|---|---|
Novartis Pharma AG
 Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland. | Corporate Officer/Principal | 01/07/2020 |
| ADAPTIMMUNE THERAPEUTICS PLC | Corporate Officer/Principal | 01/02/2016 |
Cullinan Oncology LLC
 Cullinan Oncology LLC Financial ConglomeratesFinance Cullinan Oncology LLC is a biopharmaceutical company, which engages in the development of a pipeline of targeted oncology and immuno-oncology therapies for cancer diseases. The company was founded by Patrick Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA. | Director/Board Member | - |
Training of Anne-Marie Martin
| Sheffield Hallam University | Undergraduate Degree |
| MCP Hahnemann University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| CULLINAN THERAPEUTICS, INC. | Health Technology |
| ADAPTIMMUNE THERAPEUTICS PLC | Health Technology |
| GSK PLC | Health Technology |
| Private companies | 2 |
|---|---|
Cullinan Oncology LLC
Cullinan Oncology LLC Financial ConglomeratesFinance Cullinan Oncology LLC is a biopharmaceutical company, which engages in the development of a pipeline of targeted oncology and immuno-oncology therapies for cancer diseases. The company was founded by Patrick Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA. | Finance |
Novartis Pharma AG
Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland. | Health Technology |
- Stock Market
- Insiders
- Anne-Marie Martin
